Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	GILDGilead Sciences	AMGNAmgen	VRTXVertex Pharmaceuticals
Snapshot
Price	$153.15	$409.05	$519.39
Market cap	$162.98B	$201.93B	$115.02B
Valuation
P/E	20.5x	28.5x	28.7x
Forward P/E	14.6x	21.7x	27x
Growth
Revenue growth	3.5%	9.1%	10.1%
EPS growth	55.5%	31.3%	6.1%
Profitability
Net margin	31.0%	21.0%	35.5%
ROE	42.2%	89.4%	23.9%
Balance sheet & cash
Debt / equity	1.1x	6.31x	0.01x
Free cash flow yield	5.2%	6.0%	3.1%
Dividend yield	2.6%	2.9%	—
Verdict
Investment rating	Strong· 74	Favorable· 62	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	GILDtoday $153	AMGNtoday $409	VRTXtoday $519
2027	$178.60 – $261.95+71% CAGR	$402.72 – $590.66+44% CAGR	$413.38 – $606.29+17% CAGR
2028	$277.70 – $407.30+63% CAGR	$528.65 – $775.35+38% CAGR	$438.68 – $643.40+11% CAGR
2029	$431.80 – $633.31+61% CAGR	$693.96 – $1,017.81+36% CAGR	$465.53 – $682.78+10% CAGR
2030	$671.41 – $984.74+59% CAGR	$910.96 – $1,336.08+34% CAGR	$494.02 – $724.56+9% CAGR
2031	$1,043.98 – $1,531.17+58% CAGR	$1,195.82 – $1,753.87+34% CAGR	$524.25 – $768.90+8% CAGR
5-yr CAGR	46.8% – 58.5%	23.9% – 33.8%	0.2% – 8.2%